Tags » Superbug

AAPS Pharmaceutical Science Roundup, November 2014

This month’s roundup features stories about the connection between animals and drug development, medical marijuana, and “exercise in a bottle.”

Have a perspective on one of these stories?  114 more words


The Traveling Superbug: From Farms to Homes

Antibiotics are creating untreatable diseases that grow more resistant each day.  These diseases are formed when animals are fed an overabundance of antibiotics.  The longer this problem remains unresolved, the more threatening it will become.  495 more words


Battles with a Superbug

I got really sick.

I mean really sick, as in I couldn’t move from my bed to my couch without sweating profusely and wanting to faint. 512 more words


Melinta Therapeutics Demonstrates Potent In Vitro Activity of New Antibiotic Class against Gram Negative ESKAPE Pathogens

NEW HAVEN, Conn, Sept. 8, 2014 — Melinta Therapeutics today provided an update on the Company’s innovative ESKAPE Pathogen Program. The ESKAPE Pathogen Program leverages Melinta’s knowledge and experience in crystallography and computational chemistry to generate new classes of antibiotics and new molecules within those classes to treat the extensively drug resistant (XDR) and multi-drug resistant (MDR) “superbug” bacteria, also known as the ESKAPE pathogens. 757 more words

Dr. Erin Duffy

Antibiotics 2.0

Wow, so its been a good few weeks since my last post.

So on to the subject of antibiotics. It seems that at least once a month, there is a new story in the news and tabloids about  “superbugs” (basically bacteria that are resistant to antibiotics such as MRSA)  claiming that we are at the end the the antibiotic era, stating that the increasing levels of antibiotic resistance are pushing us back to a time when even the smallest cut could kill you: 453 more words